These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 17991882

  • 1. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis.
    Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S, Krohn R, Schober A, Sperandio M, Soehnlein O, Bornemann J, Tacke F, Biessen EA, Weber C.
    Circ Res; 2008 Feb 01; 102(2):209-17. PubMed ID: 17991882
    [Abstract] [Full Text] [Related]

  • 2. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
    Vroon A, Heijnen CJ, Raatgever R, Touw IP, Ploemacher RE, Premont RT, Kavelaars A.
    J Leukoc Biol; 2004 Apr 01; 75(4):698-704. PubMed ID: 14704365
    [Abstract] [Full Text] [Related]

  • 3. Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation.
    de Jager SC, Bot I, Kraaijeveld AO, Korporaal SJ, Bot M, van Santbrink PJ, van Berkel TJ, Kuiper J, Biessen EA.
    Arterioscler Thromb Vasc Biol; 2013 Mar 01; 33(3):e75-83. PubMed ID: 23288165
    [Abstract] [Full Text] [Related]

  • 4. Rapid and recurrent neutrophil mobilization regulated by T134, a CXCR4 peptide antagonist.
    Iyer CV, Evans RJ, Lou Q, Lin D, Wang J, Kohn W, Yan LZ, Pulley S, Peng SB.
    Exp Hematol; 2008 Sep 01; 36(9):1098-109. PubMed ID: 18495324
    [Abstract] [Full Text] [Related]

  • 5. Deficiency of endothelial CXCR4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice.
    Noels H, Zhou B, Tilstam PV, Theelen W, Li X, Pawig L, Schmitz C, Akhtar S, Simsekyilmaz S, Shagdarsuren E, Schober A, Adams RH, Bernhagen J, Liehn EA, Döring Y, Weber C.
    Arterioscler Thromb Vasc Biol; 2014 Jun 01; 34(6):1209-20. PubMed ID: 24723559
    [Abstract] [Full Text] [Related]

  • 6. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S, Combadière C, Esposito B, Lecureuil C, Ait-Oufella H, Merval R, Ardouin P, Tedgui A, Mallat Z.
    Arterioscler Thromb Vasc Biol; 2006 Aug 01; 26(8):1858-63. PubMed ID: 16763157
    [Abstract] [Full Text] [Related]

  • 7. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
    Chen GS, Yu HS, Lan CC, Chow KC, Lin TY, Kok LF, Lu MP, Liu CH, Wu MT.
    Br J Dermatol; 2006 May 01; 154(5):910-8. PubMed ID: 16634895
    [Abstract] [Full Text] [Related]

  • 8. Inhibitors of CXC chemokine receptor type 4: putative therapeutic approaches in inflammatory diseases.
    Hummel S, Van Aken H, Zarbock A.
    Curr Opin Hematol; 2014 Jan 01; 21(1):29-36. PubMed ID: 24275689
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice.
    Babaev VR, Ding L, Reese J, Morrow JD, Breyer MD, Dey SK, Fazio S, Linton MF.
    Circulation; 2006 Jan 03; 113(1):108-17. PubMed ID: 16380543
    [Abstract] [Full Text] [Related]

  • 10. Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice.
    van Leeuwen M, Gijbels MJ, Duijvestijn A, Smook M, van de Gaar MJ, Heeringa P, de Winther MP, Tervaert JW.
    Arterioscler Thromb Vasc Biol; 2008 Jan 03; 28(1):84-9. PubMed ID: 17991873
    [Abstract] [Full Text] [Related]

  • 11. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
    Mikami S, Nakase H, Yamamoto S, Takeda Y, Yoshino T, Kasahara K, Ueno S, Uza N, Oishi S, Fujii N, Nagasawa T, Chiba T.
    J Pharmacol Exp Ther; 2008 Nov 03; 327(2):383-92. PubMed ID: 18716065
    [Abstract] [Full Text] [Related]

  • 12. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG, Zhu Y, Coleman T, Semenkovich CF.
    Arterioscler Thromb Vasc Biol; 2007 Dec 03; 27(12):2699-706. PubMed ID: 17951320
    [Abstract] [Full Text] [Related]

  • 13. CXCR4 blockade induces atherosclerosis by affecting neutrophil function.
    Bot I, Daissormont IT, Zernecke A, van Puijvelde GH, Kramp B, de Jager SC, Sluimer JC, Manca M, Hérias V, Westra MM, Bot M, van Santbrink PJ, van Berkel TJ, Su L, Skjelland M, Gullestad L, Kuiper J, Halvorsen B, Aukrust P, Koenen RR, Weber C, Biessen EA.
    J Mol Cell Cardiol; 2014 Sep 03; 74():44-52. PubMed ID: 24816217
    [Abstract] [Full Text] [Related]

  • 14. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
    Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, Kooistra T, Fingerle-Rowson G, Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C.
    Nat Med; 2007 May 03; 13(5):587-96. PubMed ID: 17435771
    [Abstract] [Full Text] [Related]

  • 15. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J, Egashira K, Matoba T, Kubo M, Ihara Y, Iwai M, Horiuchi M, Sunagawa K.
    Hypertens Res; 2008 Sep 03; 31(9):1791-800. PubMed ID: 18971558
    [Abstract] [Full Text] [Related]

  • 16. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
    Muñoz-García B, Moreno JA, López-Franco O, Sanz AB, Martín-Ventura JL, Blanco J, Jakubowski A, Burkly LC, Ortiz A, Egido J, Blanco-Colio LM.
    Arterioscler Thromb Vasc Biol; 2009 Dec 03; 29(12):2061-8. PubMed ID: 19778942
    [Abstract] [Full Text] [Related]

  • 17. Open sesame! CXCR4 blockade recruits neutrophils into the plaque.
    Sainz J, Sata M.
    Circ Res; 2008 Feb 01; 102(2):154-6. PubMed ID: 18239145
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.
    Bodart V, Anastassov V, Darkes MC, Idzan SR, Labrecque J, Lau G, Mosi RM, Neff KS, Nelson KL, Ruzek MC, Patel K, Santucci Z, Scarborough R, Wong RS, Bridger GJ, Macfarland RT, Fricker SP.
    Biochem Pharmacol; 2009 Oct 15; 78(8):993-1000. PubMed ID: 19540208
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.